Patient preferences for chemotherapies used in breast cancer

by Beusterien K, Grinspan J, Tencer T, Brufsky A, Visovsky C
Published 2012-06-01

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment

by Kumar J, Cambron-Mellott MJ, Tencer T, Will O, Mackie dS, Beusterien K
Published 2021-07-01

Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment

by Beusterien K, Maculaitis MC, Hallissey B, Gaschler MM, Smith ML, Law EH
Published 2021-03-01

Patient preferences in the treatment of diabetic retinopathy

by Wirostko B, Beusterien K, Grinspan J, Ciulla T, Gonder J, Barsdorf A, Pleil A
Published 2011-05-01

Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema

by Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Boysen HB, Caballero T
Published 2016-09-01

Quantifying the treatment goals of people recently diagnosed with schizophrenia using best–worst scaling

by Bridges JFP, Beusterien K, Heres S, Such P, Sánchez-Covisa J, Nylander AG, Chan E, de Jong-Laird A
Published 2018-01-01

Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment

by Cambron-Mellott MJ, Mikl J, Matos JE, Erensen JG, Beusterien K, Cataldo MJ, Hallissey B, Mattingly GW
Published 2021-05-01

Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment

by Joko T, Nagai Y, Mori R, Tanaka K, Oshima Y, Hikichi Y, Komori T, Carrasco J, Maculaitis MC, Will O, Beusterien K, Takahashi K
Published 2020-03-01

Japanese patient preferences regarding intermediate to advanced hepatocellular carcinoma treatments

by Chiba T, Hiraoka A, Mikami S, Shinozaki M, Osaki Y, Obu M, Ohki T, Mita N, Ledesma D, Yoshihara N, Beusterien K, Amos K, Bridges JFP, Yokosuka O
Published 2019-04-01